Square Plus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Net Worth
- Total Assets 0.06%
(FY 2022)
About Square Plus Life Sciences
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Laxminarayan Moondra, Sunil Laxminarayana, Sushil Mundra, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900KA2014PTC073459
- Company No.
073459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2014
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Square Plus Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Laxminarayana  | Director | 06-Feb-2014 | Current |
| Laxminarayan Moondra | Director | 06-Feb-2014 | Current |
| Sushil Mundra | Director | 06-Feb-2014 | Current |
| Sathyanarayana Mundra | Director | 06-Feb-2014 | Current |
Financial Performance of Square Plus Life Sciences.
Square Plus Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Square Plus Life Sciences?
In 2021, Square Plus Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Natural Capsules LimitedActive 31 years 3 monthsLaxminarayan Moondra, Sunil Laxminarayana and 2 more are mutual person
- Natural Biogenex Private LimitedActive 4 years 4 months
Laxminarayan Moondra and Sunil Laxminarayana are mutual person
Tajos Investments Private LimitedActive 30 years 10 monthsLaxminarayan Moondra and Sunil Laxminarayana are mutual person
- Natural Phyto Pharma Private LimitedActive 6 years 2 months
Sunil Laxminarayana and Sushil Mundra are mutual person
- Nandi Synthetics Private LimitedActive 39 years 4 months
Sushil Mundra and Sathyanarayana Mundra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Square Plus Life Sciences?
Unlock and access historical data on people associated with Square Plus Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Square Plus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Square Plus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
